Medical Marijuana I Stock Net Asset
| MJNA Stock | USD 0.0002 0.0001 33.33% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Medical Marijuana's long-term financial health and intrinsic value.
Medical |
Medical Marijuana I Company Net Asset Analysis
Medical Marijuana's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Based on the recorded statements, Medical Marijuana I has a Net Asset of 0.0. This indicator is about the same for the Health Care Providers & Services average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Medical Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medical Marijuana's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Medical Marijuana could also be used in its relative valuation, which is a method of valuing Medical Marijuana by comparing valuation metrics of similar companies.Medical Marijuana is currently under evaluation in net asset category among its peers.
Medical Fundamentals
| Return On Equity | 0.12 | |||
| Return On Asset | -0.0146 | |||
| Profit Margin | 0.15 % | |||
| Operating Margin | (0.04) % | |||
| Current Valuation | 62.53 M | |||
| Shares Outstanding | 3.44 B | |||
| Price To Earning | 5.25 X | |||
| Price To Book | 0.55 X | |||
| Price To Sales | 0.86 X | |||
| Revenue | 58.98 M | |||
| Gross Profit | 57.73 M | |||
| EBITDA | 1.45 M | |||
| Net Income | 84.4 M | |||
| Cash And Equivalents | 4.68 M | |||
| Total Debt | 10.41 M | |||
| Debt To Equity | 0.13 % | |||
| Current Ratio | 1.92 X | |||
| Book Value Per Share | 0.02 X | |||
| Cash Flow From Operations | 86.86 M | |||
| Earnings Per Share | 0 X | |||
| Number Of Employees | 91 | |||
| Beta | 1.12 | |||
| Market Capitalization | 56.49 M | |||
| Total Asset | 209.53 M | |||
| Retained Earnings | 31.14 M | |||
| Working Capital | 8.65 M | |||
| Current Asset | 14.02 M | |||
| Current Liabilities | 5.37 M | |||
| Z Score | 3.0 |
About Medical Marijuana Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medical Marijuana I's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medical Marijuana using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medical Marijuana I based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Medical Pink Sheet
Medical Marijuana financial ratios help investors to determine whether Medical Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medical with respect to the benefits of owning Medical Marijuana security.